ZeroStack (ZSTK) Stock Forecast: StockMap's 2-Week Call
ZSTK stock forecast: StockMap's model leans Underperform on ZeroStack for the two weeks after the Nov 19 close, toward ZSTK trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 3 of 4 two-week windows on ZSTK since Aug 21; by chance, a call on the same dates was right 69% of the time.
ZeroStack last closed at $2.91, +1.04% on the session.
Against the IVW growth benchmark the position is +3.37% over the forecast window.
ZeroStack's market cap is $50.90M as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -48 (too close to call).
Where ZSTK sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 2 bullish and 13 bearish.
Agreement across those insights is 87%.
28 daily calls for ZSTK so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks ZeroStack in the 3rd percentile on return on equity, where 100 is best.
ZeroStack is classified under Health Care / Health Care Providers & Services.
StockMap tracks ZeroStack as the 77th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite ZeroStack ranks 82nd of 87 in the group, against a group median of -0.06.